← Eichor
Study identifier: NCT05233722 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

mTOR as Mediator of Insulin Sensitivity Study

Condition: Insulin Sensitivity  ·  Sponsor: University of Copenhagen

PhaseNA
Planned participants10
Who can joinMale, 22 Years to 35 Years
Healthy volunteersYes

About this study

The study investigates the role of mTOR in mediating enhancement of muscle insulin sensitivity following a single bout of exercise. This will be investigated in young healthy male subjects by administering the pharmacological mTOR inhibitor Rapamycin in a crossover blinded experimental setup known to enhance muscle insulin sensitivity following one-legged knee-extensor exercise.

This description comes directly from the study's public registry record.

Talk to the study team

Jørgen FP Wojtaszewski, Professor  ·  +4535321625  ·  jw@nexs.ku.dk

Magnus R Larsen, MSc  ·  +4540186274  ·  Marl@nexs.ku.dk

Always discuss trial participation with your own doctor first.

Locations (1)

University of CopenhagenCopenhagen, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05233722